I. G. Ghobadi Moghaddam-Helmantel

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.

E. Wiemer, R. Mathijssen, P. de Bruijn, 2011, Journal of pharmaceutical and biomedical analysis.

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

E. Wiemer, R. Mathijssen, J. Ijzermans, 2016, British journal of pharmacology.

Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation

E. Wiemer, R. Mathijssen, H. Burger, 2016, The Prostate.

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

S. Sleijfer, E. Wiemer, J. Verweij, 2010, Cancer Chemotherapy and Pharmacology.

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment

A. Jager, R. Mathijssen, R. V. van Schaik, 2022, Therapeutic advances in medical oncology.

Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

C. Gui, A. Gibson, A. Sparreboom, 2014, Cancer research.

Influence of Darolutamide on Cabazitaxel Systemic Exposure

R. Mathijssen, P. de Bruijn, R. de Wit, 2022, Clinical Pharmacokinetics.